Vishwanath Kalkundrikar Criou um novo artigo
7 horas

Stomach Cancer Drugs: Strengthening Targeted Therapeutics in Oncology Care | #stomach Cancer Drugs

Stomach Cancer Drugs: Strengthening Targeted Therapeutics in Oncology Care

Stomach Cancer Drugs: Strengthening Targeted Therapeutics in Oncology Care

The global current value of Stomach Cancer Drugs was valued at USD 4.30 billion in 2024, and is projected to reach USD 6.83 billion by 2035, growing at a CAGR of 4.29% from 2025–2035.